Skip to main content
. 2019 Aug 26;56(10):701–710. doi: 10.1136/jmedgenet-2018-105879

Table 3.

Gender, age and inheritance status by carrier group and ascertainment

CNV Carrier group No. Sex ratio Mean age,
years (SD)
De novo frequency, no.
(95% CI)
M F M/F ratio (95% CI), P value
Deletion All probands 326 200 126 (0.56 to 0.67), 4.9e−05 8.7 (9.1) 5.9%, 8/136 (2.6 to 11.3)
Probands +NDD 266 179 87 (0.61 to 0.73), 1.8e−08 9.3 (7.3) 7.4%, 8/108 (3.3 to 14.1)
Probands −NDD 60 21 39 (0.24 to 0.48), ns 8.9 (14.5) 0/28
Relative carriers 65 32 33 1.0, ns 32.0 (15.9) 0/15
Duplication All probands 176* 110 65 (0.55 to 0.70), 8.3e−04 7.8 (9.0) 2.2%, 1/46 (0.1 to 11.5)
Probands +NDD 139* 91 47 (0.57 to 0.74), 2.3e−04 8.7 (7.9) 2.4%, 1/42 (0.1 to 12.6)
Probands −NDD 37 19 18 1.0, ns 9.0 (12.6) 0/4
Relative carriers 38 19 19 1.0, ns 32.0 (16.2) 0/8

*The sex of one duplication proband is unknown.

CI, confidence interval; F, female; M, male; −NDD, probands not ascertained for NDD; +NDD, probands ascertained for neurodevelopmental disorder; SD, standard deviation; ns, not significant.